NCT02796781View on ClinicalTrials.gov

Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 12, 2016

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Interstitial Lung Diseases
Interventions
BIOLOGICAL

Lung stem cells

Patients will receive clinical grade lung stem cells (LSCs)injected into lung via fiberoptic bronchoscopy.

Trial Locations (1)

200123

Shanghai East Hospital, Shanghai

All Listed Sponsors
collaborator

Regend Therapeutics

INDUSTRY

lead

Shanghai East Hospital

OTHER

NCT02796781 - Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases | Biotech Hunter | Biotech Hunter